Sheng, X., Shen, P., Wang, Z., Ren, X., Li, Y., Jiang, S., Li, G., Zeng, Y., Qin, W., Wu, J., Chen, P., Zhou, F., Guo, H., Ji, Z., Wang, Y., He, Z., Shi, B., Liu, L., Zhou, A., Guo, J. (2025). First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma: Subgroup analysis from the phase 3 ETER100 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4536